Reduction in blood pressure, sympathetic nerve discharge and centrally evoked pressor responses by methysergide in anesthetized cats
- PMID: 852503
- DOI: 10.1016/0014-2999(77)90166-2
Reduction in blood pressure, sympathetic nerve discharge and centrally evoked pressor responses by methysergide in anesthetized cats
Abstract
Methysergide (1 and 3 mg/kg i.v.) caused dose-dependent reductions in blood pressure and heart rate of anesthetized cats. In addition, sympathetic nerve discharges of the postganglionic renal nerve were also markedly reduced by the same doses of drug. Pressor responses to electrical stimulation of the diencephalon were inhibited by 3 mg/kg but not 1 mg/kg of methysergide. These results suggest that methysergide acts to decrease blood pressure by a centrally mediated reduction in sympathetic nervous outflow and, at higher doses, can additionally prevent pressor changes caused by electrical activation of suprabulbar central structures. These results are in agreement with previous reports that methysergide has little or no peripheral effects on the cardiovascular system.
Similar articles
-
Enhancement of reflex vagal bradycardia following intracerebroventricular administration of methysergide in cats.Eur J Pharmacol. 1979 Oct 26;59(1-2):85-93. doi: 10.1016/0014-2999(79)90027-x. Eur J Pharmacol. 1979. PMID: 510402
-
Centrally mediated antihypertensive and bradycardic effects of methysergide in spontaneously hypertensive rats.Eur J Pharmacol. 1976 Apr;36(2):451-4. doi: 10.1016/0014-2999(76)90101-1. Eur J Pharmacol. 1976. PMID: 1278233
-
Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats.Eur J Pharmacol. 2009 Jun 10;612(1-3):80-6. doi: 10.1016/j.ejphar.2009.03.072. Epub 2009 Apr 6. Eur J Pharmacol. 2009. PMID: 19356724
-
Efferent discharges of sympathetic and parasympathetic nerve fibers during increased intracranial pressure in anesthetized cats in the absence and presence of pressor response.Brain Res. 1984 Jul 9;305(2):291-301. doi: 10.1016/0006-8993(84)90435-9. Brain Res. 1984. PMID: 6744068
-
The effects of ketanserin, methysergide and LY 53857 on sympathetic nerve activity.Eur J Pharmacol. 1985 Jul 31;113(3):295-303. doi: 10.1016/0014-2999(85)90076-7. Eur J Pharmacol. 1985. PMID: 2931285
Cited by
-
The effects of the 5 HT2 antagonist ritanserin on blood pressure and serotonin-induced platelet aggregation in patients with untreated essential hypertension.Eur J Clin Pharmacol. 1988;35(2):123-9. doi: 10.1007/BF00609240. Eur J Clin Pharmacol. 1988. PMID: 3142775 Clinical Trial.
-
Pharmacology of centrally acting hypotensive drugs.Br J Clin Pharmacol. 1980;10 Suppl 1(Suppl 1):13S-20S. doi: 10.1111/j.1365-2125.1980.tb04899.x. Br J Clin Pharmacol. 1980. PMID: 6104975 Free PMC article. Review.
-
Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus.Br J Pharmacol. 1988 Nov;95(3):975-85. doi: 10.1111/j.1476-5381.1988.tb11728.x. Br J Pharmacol. 1988. PMID: 3207999 Free PMC article.
-
Examination of the effects of some 5-HT2 receptor antagonists on central sympathetic outflow and blood pressure in anaesthetised cats.Naunyn Schmiedebergs Arch Pharmacol. 1988 Dec;338(6):601-7. doi: 10.1007/BF00165623. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 3149720
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous